Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 246 are a BUY (89.13%), 22 are a HOLD (7.97%), 8 are a SELL (2.9%).
Analyst Mitchell Kapoor, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 36.46% that have a potential upside of 28.97% achieved within 62 days.
Mitchell Kapoor’s has documented 543 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HALO, Halozyme Therapeutics at 01-Oct-2025.
Analyst best performing recommendations are on SMMT (SUMMIT THERAPEUTICS PLC).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$36
$-0.01 (-0.03%)
$36
2 years 10 months 17 days ago
(27-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Hold
$36
$-0.01 (-0.03%)
$35
2 years 10 months 23 days ago
(21-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Hold
$36
$-0.01 (-0.03%)
2 years 10 months 23 days ago
(21-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Hold
$36
$-0.01 (-0.03%)
$30
2 years 10 months 23 days ago
(21-Nov-2022)
2/2 (100%)
$0.4 (1.12%)
258
Hold
$36
$-0.01 (-0.03%)
$25
2 years 10 months 24 days ago
(20-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?